US9168171B2ActiveUtilityA1

Combination treatments

88
Assignee: ROGERS LESCO LPriority: Dec 18, 2009Filed: Dec 16, 2011Granted: Oct 27, 2015
Est. expiryDec 18, 2029(~3.4 yrs left)· nominal 20-yr term from priority
Inventors:Lesco L. Rogers
A61F 7/12A61F 2007/0005A61F 7/007A61F 2007/0093A61F 2007/0096A61F 2007/0075
88
PatentIndex Score
18
Cited by
139
References
3
Claims

Abstract

A method of treating a subject in need thereof, is carried out by (a) administering said subject a therapeutic intervention (e.g., an active agent) in a treatment effective amount; and concurrently (b) administering said subject caloric vestibular stimulation in a treatment effective amount, said caloric vestibular stimulation administered so as to enhance the efficacy of said active agent. In some embodiments, the caloric vestibular stimulation is administered as an actively controlled time varying waveform.

Claims

exact text as granted — not AI-modified
That which is claimed is:  
     
       1. A method of treating a subject in need thereof, comprising:
 (a) administering said subject an active agent in a treatment effective amount; and concurrently 
 (b) administering said subject caloric vestibular stimulation in a treatment effective amount, said caloric vestibular stimulation administered so as to enhance the efficacy of said active agent, wherein said caloric vestibular stimulation is administered as an actively controlled time varying waveform and the subject is afflicted with premenstrual dysphoric disorder, and said active agent comprises an active agent for treating premenstrual dysphoric disorder. 
 
     
     
       2. The method of  claim 1 , wherein said active agent is administered orally. 
     
     
       3. The method of  claim 1 , wherein said caloric vestibular stimulation is administered for a time sufficient to induce nystagmus over a period of at least five minutes.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.